Hochschulschrift
Nephroprotektion durch SGLT2-Inhibition : Effekte auf Tubulusproteom, -metabolom und cardiorenalen Crosstalk
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
125 Seiten
- Language
-
Deutsch
- Notes
-
Illustrationen, Diagramme
Universität Regensburg, Dissertation, 2023
- Keyword
-
Tiermodell
Proteomanalyse
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:57 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2023
Other Objects (12)
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
SGLT2 and cancer
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
SGLT2 and cancer
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
SGLT2 and cancer
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus